Toggle light / dark theme

Alzheimer’s risk calculator could spot danger years before symptoms begin

Mayo Clinic researchers have developed a new tool that can estimate a person’s risk of developing memory and thinking problems associated with Alzheimer’s disease years before symptoms appear.

The research, published in The Lancet Neurology, builds on decades of data from the Mayo Clinic Study of Aging—one of the world’s most comprehensive population-based studies of .

The study found that women have a higher than men of developing and (MCI), a transitional stage between healthy aging and dementia that often affects quality of life but still allows people to live independently. Men and women with the common genetic variant, APOE ε4, also have a higher lifetime risk.

Want a younger brain? Learn another language

Speaking multiple languages could slow down brain ageing and help to prevent cognitive decline, a study of more than 80,000 people has found.

The work, published in Nature Aging on 10 November1, suggests that people who are multilingual are half as likely to show signs of accelerated biological ageing as are those who speak just one language.

“We wanted to address one of the most persistent gaps in ageing research, which is if multilingualism can actually delay ageing,” says study co-author Agustín Ibáñez, a neuroscientist at the Adolfo Ibáñez University in Santiago, Chile. Previous research in this area has suggested that speaking multiple languages can improve cognitive functions such memory and attention2, which boosts brain health as we get older. But many of these studies rely on small sample sizes and use unreliable methods of measuring ageing, which leads to results that are inconsistent and not generalizable.

“The effects of multilingualism on ageing have always been controversial, but I don’t think there has been a study of this scale before, which seems to demonstrate them quite decisively,” says Christos Pliatsikas, a cognitive neuroscientist at the University of Reading, UK. The paper’s results could “bring a step change to the field”, he adds.

They might also “encourage people to go out and try to learn a second language, or keep that second language active”, says Susan Teubner-Rhodes, a cognitive psychologist at Auburn University in Alabama.


How Do Your Age and Diet Influence Your Thinking?

Having too many fat cells can lead to low-grade, body-wide inflammation that underlies brain aging.

Chronic venous insufficiency due to obesity may impair cognitive function.

It’s never too late to positively impact brain aging by losing weight.


Mind wandering, confusion, and a reduced ability to focus thoughts are classic early symptoms of obesity related cognitive decline.

This neural interface writes code from my brain waves… — YouTube

Check out Neurosity to code with your brain waves — https://neurosity.co/fireship.

I gave Claude Code full access to my mind to find out if it’s really possible to vibe code straight from the dome using the Neurosity Crown. Let’s run it…

#coding #programming #tech.

💬 Chat with Me on Discord.

https://discord.gg/fireship.

🔗 Resources.

Newly discovered RNA molecule could limit protein aggregation and prevent neuronal damage

Neurodegenerative diseases, such as Alzheimer’s disease and dementia, are medical conditions that entail the progressive loss of neurons and a decline in brain function. Past studies have found a link between these diseases and the buildup of misfolded proteins, such as tau and α-synuclein.

Tau is a protein found primarily in neurons that typically helps to stabilize structures that transport nutrients and molecules within neurons, known as microtubules. α-synuclein, on the other hand, is a small protein located at the tips of neurons (i.e., pre-synapses), which typically helps to regulate the function of synaptic vesicles, small sacs that release neurotransmitters across synapses.

While these proteins have an important function in the healthy brain, their abnormal has been found to be a hallmark of several neurodegenerative diseases. The that prompt their accumulation, however, have not yet been fully elucidated.

Shared gut microbe imbalances found across autism, ADHD, and anorexia nervosa

A new study has identified distinct patterns in the gut bacteria of children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and anorexia nervosa. Published in the journal Neuroscience, the research also reveals altered levels of hormones that regulate appetite, suggesting a complex interplay between gut microbes, eating behaviors, and brain health in these conditions.

The human digestive tract is home to a bustling community of trillions of microorganisms, collectively known as the gut microbiota. This internal ecosystem communicates with the brain through a complex network of signals, often called the gut-brain axis. Researchers are increasingly recognizing that an imbalance in this microbial community, sometimes referred to as dysbiosis, may be associated with a range of health conditions, including those affecting the brain.

Neurodevelopmental disorders like autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD), along with the psychiatric disorder anorexia nervosa (AN), are frequently accompanied by gastrointestinal issues and atypical eating patterns.

Functional Connectivity Changes in Traumatic Brain InjuryA Systematic Review and Coordinate-Based Meta-Analysis of fMRI Studies

Importance There lacks data clarifying the meningioma risk conferred by depot medroxyprogesterone acetate in the US.

Objective To examine the relative risk of meningioma diagnosis in women using depot medroxyprogesterone acetate and other related progestins.

Design, Setting, and Participants This retrospective population-based cohort study used data from TriNetX, a US national database of 68 health care organizations. Data were analyzed from December 2004 to December 2024. The incidence of meningioma diagnosis was compared between treatment groups through propensity-score matched analyses. Participants included a sample of females with use of only 1 of the following progestins/contraceptives: depot medroxyprogesterone acetate, oral medroxyprogesterone acetate, combined oral contraceptives, intrauterine devices, progestin only pills, or subdermal implantable contraceptive. The control group included females without use of these hormonal treatments. Of the 118 289 082 total patients in TriNetX at the time of analysis, 61 588 239 patients were female and eligible.

/* */